Silk road medical, inc. (SILK)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities
Net loss

-9,941

-8,291

-8,007

-11,959

-24,158

-15,619

-8,953

-7,650

-5,408

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

184

182

180

176

174

192

194

74

57

Stock-based compensation expense

1,293

954

924

837

262

226

194

329

162

Change in fair value of redeemable convertible preferred stock warrant liability

0

0

0

5,318

15,712

6,999

3,229

1,894

-216

Amortization of premium on investments

-79

-

-

-

0

-

-

-

-

Amortization of debt discount and debt issuance costs

12

12

12

11

11

11

11

23

23

Amortization of right-of-use asset

146

142

140

138

162

-

-

-

-

Non-cash interest expense

83

77

40

84

471

402

371

396

386

Change in provision for doubtful accounts receivable

-9

-1,140

439

727

-3

-1,378

592

385

278

Provision for excess and obsolete inventories

92

40

35

16

27

23

0

0

0

Changes in assets and liabilities
Accounts receivable

60

-1,334

1,953

1,779

-157

-1,069

1,990

1,537

-2,012

Inventories

1,871

1,087

347

923

2,339

640

871

621

433

Prepaid expenses and other current assets

-983

-625

255

1,857

-16

691

-41

91

387

Other assets

-55

212

-8

-1,407

651

4

6

69

-17

Accounts payable

1,274

-97

757

-2,332

2,287

256

-589

268

-244

Accrued liabilities

-3,912

2,709

1,878

56

321

3,644

1,209

1,067

-897

Other liabilities

-203

-200

-197

697

-1,069

-39

201

244

0

Net cash used in operating activities

-11,795

-5,261

-6,346

-9,383

-8,620

-5,390

-6,367

-5,288

-4,650

Cash flows from investing activities
Purchases of property and equipment

134

198

131

89

117

108

1,164

549

455

Purchases of investments

1,974

-

-

-

0

-

-

-

-

Proceeds from maturity of investments

2,000

-

-

-

0

-

-

-

-

Net cash used in investing activities

-108

-69,619

-131

-89

-117

-102

-1,164

-549

-455

Cash flows from financing activities
Payment of deferred offering costs

0

-

-

-

1,149

-

-

-

0

Proceeds from issuance of common stock

274

1,784

68

363

375

7

217

148

284

Proceeds from exercise of redeemable convertible preferred stock warrants

-

-

-

-

-

-

-

-

0

Net cash provided by (used in) financing activities

274

1,784

507

112,210

-744

-226

15,218

148

284

Net change in cash, cash equivalents and restricted cash

-11,629

-73,096

-5,970

102,738

-9,481

-5,718

7,687

-5,689

-4,821

Supplemental disclosure of cash flow information
Cash paid for interest

1,108

1,127

1,125

1,112

870

883

683

592

580

Non-cash investing and financing activities:
Accounts payable and accrued liabilities for purchases of property and equipment

22

23

2

-15

22

-20

-670

606

90

Offering costs in accounts payable and accrued liabilities

0

-

-

-846

1,204

-

-

0

0

Right-of-use asset obtained in exchange for lease obligation

0

0

0

0

3,982

-

-

-

-

Redeemable Convertible Preferred Stock
Proceeds from exercise of redeemable convertible preferred stock warrants

0

0

0

1,754

30

-

-

-

-